
In the News
December 15, 2022
Chimeron Bio Appoints Antonin (Tony) de Fougerolles to its Board of Directors
Philadelphia, PA – December 15, 2022 – Chimeron Bio, an RNA company developing self-amplifying RNA (saRNA) vaccines and therapeutics designed on its proprietary ChaESAR™ RNA delivery platform, announced today that Antonin (Tony) de Fougerolles had been appointed as the newest member of its Board of Directors. As the former founding CSO of Moderna, Tony is […]